JPS6217188B2 - - Google Patents
Info
- Publication number
- JPS6217188B2 JPS6217188B2 JP14777277A JP14777277A JPS6217188B2 JP S6217188 B2 JPS6217188 B2 JP S6217188B2 JP 14777277 A JP14777277 A JP 14777277A JP 14777277 A JP14777277 A JP 14777277A JP S6217188 B2 JPS6217188 B2 JP S6217188B2
- Authority
- JP
- Japan
- Prior art keywords
- latex
- reagent
- antibody
- antigen
- particles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004816 latex Substances 0.000 claims description 64
- 229920000126 latex Polymers 0.000 claims description 64
- 239000002245 particle Substances 0.000 claims description 51
- 239000003153 chemical reaction reagent Substances 0.000 claims description 47
- 238000000034 method Methods 0.000 claims description 31
- 239000000203 mixture Substances 0.000 claims description 21
- 239000000427 antigen Substances 0.000 claims description 9
- 102000036639 antigens Human genes 0.000 claims description 9
- 108091007433 antigens Proteins 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 230000001464 adherent effect Effects 0.000 claims description 8
- 230000003287 optical effect Effects 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000004458 analytical method Methods 0.000 description 16
- 210000002966 serum Anatomy 0.000 description 12
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 10
- 229960005156 digoxin Drugs 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 9
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 9
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 8
- 241000282414 Homo sapiens Species 0.000 description 8
- 229940098773 bovine serum albumin Drugs 0.000 description 8
- 229940027941 immunoglobulin g Drugs 0.000 description 8
- 239000000725 suspension Substances 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 6
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 229960003387 progesterone Drugs 0.000 description 5
- 239000000186 progesterone Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 229940034208 thyroxine Drugs 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000011236 particulate material Substances 0.000 description 4
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 239000004793 Polystyrene Substances 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 3
- 229920002223 polystyrene Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 206010064127 Solar lentigo Diseases 0.000 description 2
- 102000004338 Transferrin Human genes 0.000 description 2
- 108090000901 Transferrin Proteins 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000012581 transferrin Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 101100028789 Arabidopsis thaliana PBS1 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 102000004641 Fetal Proteins Human genes 0.000 description 1
- 108010003471 Fetal Proteins Proteins 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical compound OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 101000942118 Homo sapiens C-reactive protein Proteins 0.000 description 1
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 1
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 102000004576 Placental Lactogen Human genes 0.000 description 1
- 108010003044 Placental Lactogen Proteins 0.000 description 1
- 239000000381 Placental Lactogen Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 102000050459 human LTF Human genes 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000005691 oxidative coupling reaction Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Description
æ¬çºæã¯ç¹ã«è¡æž
ã®ãããªçç©åŠç液äœãšã¯é
ããªã液äœäžã«æåãŸãã¯æäœã®ååšãå®ããã
ãã®ãã®æ¶²äœã®åæã«é¢ãããã®ã§ãããæ¬æ现
æžã«ãããŠã¯ãèšå·AgãAbããã³AbïŒAgã¯ã
ãããæåïŒãã®ããšã°ã«ã¯ä»çäœïŒhapteneïŒ
ããã³æäœãŸãã¯åæ§ãªçµåããçœè³ªã«ãã€ãŠçµ
åããããä»ã®ç©è³ªãå«ãïŒãæäœïŒåæ§ãªçµå
ããçœè³ªãå«ãïŒããã³æäœïŒæåè€åäœãæå³
ãããã®ãšããŠäœ¿ãããã Agã¯é©åœãªAbãšåå¿ããŠAbïŒAgãäœããã®
ã§ãããããŠå€§æµã®å ç«åææ³ããã®åå¿ãå©çš
ããŠããããšã¯ããç¥ãããŠãããããã«ãŸãã
ãªã¹ãã¬ã³ïŒäžè¬çã«ã©ããã¯ã¹ãšåŒã¶ïŒã®ãã
ãªåŸ®ç²åç©è³ªãAbãŸãã¯Agã§ã³ãŒãã³ã°ãã次
ãã§ã³ãŒãã³ã°ãããç²åãè©Šéšããè©Šæ溶液ã«
ãããããããŠãã®ç²åãåçïŒaggultinateïŒ
ããããããŠã©ã®çšåºŠã«åçãããã調ã¹ãããš
ãç¥ãããŠããããã®åçã¯ïŒã€ãŸãã¯ãã以äž
ã®ã³ãŒãã³ã°ãããã©ããã¯ã¹ç²åãšåå¿ããŠå
çãèµ·ãããšã®ã§ããAbãŸãã¯Agãè©Šæäžã«å
åšããããšã瀺ããã®ã§ããã ã³ãŒãã³ã°ãããç²åã®åçã芳枬ããæè¡ã¯
å€ãã®ç¹ã«ãããŠæºè¶³ã§ãããã®ã§ããã®ã«ãå°
ããAgããªãã¡ãã®ååéãçŽ4000ãããå°ãª
ãAgã®åæã«ã¯åé¡ãããããã®ãããªAgã¯äœ¿
çšãã埮ç²åç©è³ªã«å¯Ÿãéåžžã«å°ããããã®ãã
ã«èå¥ã§ãããããªåçããã°ãã°èµ·ããªãããŸ
ãã¯ããçšåºŠãŸã§èµ·ããªãããããã€ãŠãã®æè¡
ã¯å°ããAgã®åæçšã«ã¯å šé¢çã®ä¿¡é Œã¯çœ®ããª
ãã æ¬çºæè ãã¯ä»å液äœäžã®Abããã³Agãåæ
ïŒãã®ååšã®æ€åºããã³ææã«ãããã®éã®æž¬å®
ãå ±ã«è¡ãªãïŒããæ¹è¯ãããæè¡ãéçºããã
ããã¯ç¹ã«å°ããAgïŒãŸãã¯AbïŒã®åæã«æçš
ã§ããããã€ãšå€§ããAgïŒãŸãã¯AbïŒã®åæã«
䜿ãããšãã§ããã æ¬çºæã®ïŒã€ã®å®æ ã¯æ¬¡ã®ãããªåææ³ã®æäŸ
ã§ããã (a)(i) åæãã¹ãç¹å®ã®æåãŸãã¯æäœæåãå«
ã液äœè©Šæã (ii) å®è³ªçã«åäžãªç²å寞æ³ããã€ç¬¬ïŒã®ã©ã
ãã¯ã¹ã«ããæ æããã第ïŒã®è©Šè¬ãããã³ (iii) åèšç¬¬ïŒã©ããã¯ã¹ãšç°ãªãå®è³ªçã«åäž
ãªç²å寞æ³ããã€ç¬¬ïŒã®ã©ããã¯ã¹ã«ããæ
æããã第ïŒã®è©Šè¬ããã ãããã§åèšç¬¬ïŒ
è©Šè¬ã¯åèšç¬¬ïŒè©Šè¬ãšçµåããŠåèšç¬¬ïŒãã
ã³ç¬¬ïŒã©ããã¯ã¹ãåçãããããšãã§ãã
ãããŠå°ãªããšã第ïŒè©Šè¬ã¯åèšç¹å®æåãš
çµåããŠåèšç¬¬ïŒããã³ç¬¬ïŒã©ããã¯ã¹ã®å
çãé»å®³ããããšãã§ãããã®ãšãããã®æ··
åç©ã圢æãã (b) ãã®æ··åç©ãã€ã³ããŠããŒãããŠåèšç¬¬ïŒè©Š
è¬ã競åçã«åèšç¹å®æåããã³åèšç¬¬ïŒè©Šè¬
ãšçµåããããã㊠(c) åèšç¬¬ïŒããã³ç¬¬ïŒã©ããã¯ã¹ã®åçãŸãã¯
äžåçã®çšåºŠããæ··åç©äžã®åçããŠããªãã©
ããã¯ã¹ã®å åŠçæè¡ã«ããéžæçèšæ°ã«ãã
枬å®ããããã«ããè©Šæäžã«ååšããåèšç¹å®
æåãå®éãã ããšããæãã液äœäžã®ç¹å®ã®æåãŸãã¯æäœæ
åãå®éããæ¹æ³ã æ¬çºæã®æ¹æ³ã«åŸã€ãŠãïŒçš®ã®ç°ãªãã©ããã¯
ã¹è©Šè¬ãåæã«äœ¿ããããã®ç¹ãïŒçš®ã®ã©ããã¯
ã¹è©Šè¬ãã䜿ããªãå è¡æè¡ãšç°ãªããšããã§ã
ãããããïŒçš®ã®è©Šè¬ã¯ãã€ããã«æ··åããããš
ãã«åçãããæ··ååã«ã¯åçããªããã®ã§ã
ããäŸãã°äžæ¹ã®ã©ããã¯ã¹è©Šè¬ã¯AgãŸãã¯Ag
âé åç©ã§ãä»æ¹AgãŸãã¯Agâé åç©ãšçµåã
ãAbã§ããããšãã§ããããã®ïŒçš®ã®è©Šè¬ãæ··
åãããšAbã¯AgïŒãŸãã¯Agâé åç©ïŒãšçµåã
ãŠç²åã®åçãèµ·ããããããããªãã埮ç²åè©Š
è¬ã®å°ãªããšãïŒã€ã¯ãããã液äœäžã®è¢«éšç¹æ®
AbãŸãã¯Agãšçµåããããã«éžã°ãããã©ãã
ã¯ã¹è©Šè¬ãéé¢ã®AbãŸãã¯Agãšçµåããããšã¯
ã©ããã¯ã¹è©Šè¬ã®çµåäœçœ®ããµããã®ã§ããã¯ä»
ã®ã©ããã¯ã¹è©Šè¬ãšçµåããããŠåçããããšã¯
ãã¯ãã§ããªããæ··åç©äžã®åçã®çšåºŠã¯ããã
ãŠæ¶²äœäžã®ç¹æ®ãªè¢«éšAgãŸãã¯Abã®éã«äŸåã
ãéã ãæžå°ããïŒããã¯ç¹æ®ãªAgãŸãã¯Abã
ååšããªãå Žåã«æ¶²äœäžã«èµ·ãé以äžã§ããïŒã
ãã®çŸè±¡ã芳å¯ããããšã«ãã€ãŠç¹æ®ãªAbãŸã
ã¯Agã®ååšã確èªããããšãã§ãããããŠåç
ãŸãã¯äžåçã®çšåºŠã枬å®ããããšã«ãã€ãŠç¹æ®
ãªAbãŸãã¯Agã®éãå®éããããšãã§ãããã
ãã¯éåžžæã䟿å®çã«ã¯ãæ¢ç¥æ¿åºŠã®AgãŸãã¯
Abã䜿ã€ãŠåŸãããçµæããæšæºæ²ç·ãäœãã
ãããŠæ¬¡ã«è¢«éšè©Šæäžã®ãããããæªç¥ã®AbãŸ
ãã¯Agã®éãå®éããããã«ãã®æ²ç·ã䜿ãã
ãšã«ãã€ãŠè¡ãªãããã æ¬çºæã®ä¿¡ãããšããã§ã¯ãæ¬çºæã®æ¹æ³ã¯ã
ã©ã®ãããªAgã«ã䜿ãããããŠAgã§ã³ãŒãã³ã°
ãããã©ããã¯ã¹è©Šè¬ã«ãã€ãŠç¹ç°æ§ãå°å ¥ãã
ãããã©ããã¯ã¹è©Šè¬äžã«ã¯ç¹ç°ãªAbãå¿ èŠãš
ããªããããªãã¡äŸãã°ãïŒã€ã®ã©ããã¯ã¹è©Šè¬
äžã®Abã³ãŒãã³ã°ãéç¹ç°æ§ã§ãã®ããã«ãã
ã¯ïŒã€ã®ç°ãªãAgãšåå¿ããããšãã§ãããã
ãŠãããã®Agã®äžã®ãã ïŒã€ã ãïŒããªãã¡
Agâ²ïŒã液äœè©Šæããåæããããšãææããã
ãšãããšããã®å Žåã«ã¯Abãã³ãŒãã³ã°ããè©Š
è¬ãšå ±ã«Agâ²ãã³ãŒãã³ã°ããã©ããã¯ã¹è©Šè¬ã
䜿ãããšã«ãã€ãŠAgâ²ã®åæãè¡ãªãããšãã§ã
ãããã®ææ³ã¯è©Šæäžã®Abã®æ€åºããã³æž¬å®ã«
ãåãããã«ããŠäœ¿ãããšãã§ããã æ¬çºæã®æ¹æ³ã«äœ¿ãããã©ããã¯ã¹è©Šè¬ã¯é¡åŸ®
é¡çãããã¯è¶ é¡åŸ®é¡çãµã€ãºã®ãã®ã§ãããã
ãªãã¡ããã¯äžè¬ã«15ãã¯ãã³ãããå°ããæã
æ®éã«ã¯æ°ãã¯ãã³ãŸãã¯ãµããã¯ãã³ïŒïŒã
100ïœÎŒçšåºŠïŒã®ãµã€ãºã§ããããã®ãããªãµã€
ãºã®ã©ããã¯ã¹ç²åã¯åžè²©ãããŠãããã©ããã¯
ã¹ã®ãããªé¡åŸ®é¡ç埮ç²ç©è³ªã«AbãŸãã¯Agãçµ
åããããšã¯ç¥ãããŠãããããã¯éåžžç²åäžã«
åå¿æ§ã®ã³ãŒãã³ã°ãäžããããŠç²åäžã®AbãŸ
ãã¯AgãååŠçã«çµåããããããã¯åžçãã
ããšã«ãã€ãŠè¡ãªããããããæ æ³ã®å Žåã«ã¯
AbãŸãã¯AgãçŽæ¥ã«ç²åïŒãã®éã«ä»åšããã³
ãŒãã³ã°ããããªãïŒã«çµåããããšãå¯èœã§ã
ããã©ããã¯ã¹è©Šè¬ãäœãæ¹æ³ã¯æ¬çºæã®ç®çã§
ãªãªãããããŠæ¥çã§ããç¥ãããŠãããããã
ãã«ã€ããŠã¯ãã以äžèšèŒããããšã¯ããªãã æ¬çºæã®ç®çã®ããã«ã©ããã¯ã¹ã®ãããªåŸ®ç²
åç©è³ªã«çµåããããšãã§ããAgããã³Abã®äž
ã«ã¯äŸãã°æ¬¡ã®ãããªç©ããããAbãšããŠã¯å
ç«ã°ãããªã³ïŒ§ïŒIgGïŒïŒããã¯äººéã家å ãå±±
çŸããã³çŸã®è¡æž ããã®ãã®ã§ããïŒãªãã³ã«ã
ããã®ïŒŠïŒabïŒâ²ïŒæçã家å IgMãAgãšããŠã¯
人éã®IgMã人éã®èç€ã©ã¯ããŒã²ã³ã人éã®Î±
âèå ããçœè³ªïŒÎ±âfetoproteinïŒã人éã®ã©ã¯
ãããšãªã³ïŒLactoferrinïŒã人éã®è¡æž ãïŒã¢ã«
ããã³ïŒã人éã®ãã©ã³ã¹ããšãªã³
ïŒTransferrinïŒã人éã®ïŒ£âåå¿æ§ããçœè³ªãã
ã³äººéã®IgGã®Fcæçãçã®IgGããã³è¡æž ã¢ã«
ããã³ã銬ã®ããšãªãã³ïŒferritinïŒãéããçœ
質ïŒã人éãããŠã¹ãã©ããããã³ã¢ã«ã¢ããã®
IgGâ²ããã³ç²Ÿè£œããã人éã®IgGã®ïŒãïŒãïŒã
ãã³ïŒäºç¶±ããŸã人éã®è¡æž ã®ã¢ã«ããã³ãIgG
ããã³ãã©ã³ã¹ããšãªã³ãçã®ã¢ã«ããã³ããã³
ãã€ããªããŒã²ã³ããã³éŠ¬ã®ããšãªãã³ã®ããã
ã·ã³é åç©ãçµåãããããšãã§ããããŸã人é
ããã³çã®ã¢ã«ããã³ããã³çã®IgGã®ãžãŽãã·
ã³ïŒDigoxinïŒé åç©ãçµåãããããã®è¡šé¢ã«
åå¿æ§ã«ã«ããã·ã«åºããã€ãŠããããªã¹ãã¬ã³
ã©ããã¯ã¹ç²åã«ãããã·ã³ã¯çŽæ¥ã«çµåããã
ãšãã§ããã åã©ããã¯ã¹è©Šè¬ã®ç²åãµã€ãºã¯å®è³ªçã«äžæ§
ã§ããããšããã³ä»¥äžã«ãã€ãšè©³ããèšèŒããã
ãã«ç¬¬ïŒã®ã©ããã¯ã¹è©Šè¬ã®ç²åãµã€ãºã¯ç¬¬ïŒã®
ã©ããã¯ã¹è©Šè¬ã®ãããšã¯ç°ãªãïŒå°ãªããšãåŸ
è ã®ïŒåã奜ãŸããïŒãã®ã§ããããšã奜ãŸã
ãã ç¹æ®ãªAgãŸãã¯Abã®ååšãæ€åºããæ¹æ³ãå®
æœããã®ã«ã¯ãåçã®é»å®³ãèµ·ã€ããã©ããã確
蚌ããããšã ããå¿ èŠã§ããã被éšè©Šæäžã«Ag
ãŸãã¯Abãæ¯èŒç倧éã«ãããšãã«ã¯ãæ··åç©
ã¯é¡åŸ®é¡ã®ã¹ã©ã€ãã«åºããããŠããã®ã§ãé¡åŸ®
é¡ãéããŠã®èŠ³å¯ã§èçŒã§åçã®é»å®³ãæ€åºãã
ããšãã§ãããïŒã€ã®ç¹ã«å¥œãŸããè©Šéšã¯çä¹³äž
ã®ããã²ã¹ããã³ã®ååšãæ€åºããããã®ãã®ã§
ãããããã§ã¯çä¹³ãšãããã²ã¹ããã³ãŸãã¯ã
ãã²ã¹ããã³é åç©ããæãé¡åŸ®é¡çãããã¯è¶
é¡åŸ®é¡çã©ããã¯ã¹è©Šè¬ãšãããŠããã²ã¹ããã³
ããã³ããã²ã¹ããã³é åç©ã®äž¡æ¹ãšçµåãã
Abããæãé¡åŸ®é¡çãããã¯è¶ é¡åŸ®é¡çã©ãã
ã¯ã¹è©Šè¬ãšã®æ··åç©ãäœããããèçŒã§æ··åç©ã
調ã¹ããšéåžžåçé»å®³ãããããã®ã§ããããã¡
ããåçé»å®³ã®æç¡ã確蚌ããè©Šéšã«ãããŠå®é
åæã«é¢ä¿ããŠåŸè¿°ããæ¹æ³ã®ïŒã€ã䜿ãããšã
ã§ããã æ¬çºæã«ããå®éåæã§ã¯ãã©ããã¯ã¹è©Šè¬ã®
åçãŸãã¯äžåçã®çšåºŠã枬ãããšãå¿ èŠã§ã
ããããã¯çš®ã ã®æ¹æ³ã§è¡ãªãããšãã§ãããäŸ
ãã°åçããç²åãåçããªãç²åããåå¥ãã
ããããåŸè ã®æ°ã枬å®ããããšãã§ããããã®
åå¥ã¯äŸãã°ãéãé å¿åé¢ãŸãã¯ã«ã©ã ã¯ãã
ãã°ã©ãã€ã«ãã€ãŠè¡ãªãããšãã§ããã次ã«äž
åçç²åã®æ°ã枬å®ããã®ã§ããããããã«ã¯äŸ
ãã°èšæ°ã«ããããããã¯ã©ããã¯ã¹è©Šè¬äžã®ç¢º
èªã©ãã«ïŒäŸãã°æŸå°æ§ååïŒã䜿ãããšã«ãã€
ãŠæž¬ãããšãã§ããã ããããªããäžè¬ã«ããã¯é¿ããããšã奜ãŸã
ããããã¯æéãããããããŠèª€å·®ãçãæãã
ãã§ããããã®ä»£ãã«åçãäžåçã®çšåºŠãç®å®
ããããã«åå¿æ··åç©ã枬ãããšã奜ãŸãããã
ãã¯ããèªäœã¯åœæ¥çã§ç¥ãããŠããéžæçèšæ°
æè¡ã䜿ãããšã«ãã€ãŠäŸ¿å©ã«è¡ãªãããšãã§ã
ãããã®æ¹æ³ã§ã¯äŸãã°äžãããããµã€ãºç¯å²ã®
ç²åïŒãã®ç¯å²å€ã®ãµã€ãºã®ç²åã¯ç¡èŠãããïŒ
ã®æ°ãç®å®ããããšãã§ããã ããã¯è¡ãªãïŒã€ã®æ¢ç¥è£ 眮ã¯ãã¯ãã³ã³èªå
èšæ°åšïŒTechnicon AutocouuterïŒã§ããããã®
åºæ¬åã«ãããŠã¯ããã®è£ 眮ã¯åžéãããè©Šæã
å æã«çŽè§ã«ãã³ãã§éããããããŒã»ã«
ïŒFlowcellïŒãå ãééãããããªå åŠç³»ããæ
ããã®ã§ãããå åŠç³»ã®ä»ã®ç«¯ã¯å é»æ± ãããã
ãããŠãããŒã»ã«ã®ããåŸã«ã¯äžå¿ã«é»ç¹ããã€
ãã¬ã³ãºãããããã®é»ç¹ã¯ãããŒã»ã«ãçŽæ¥ã«
éã€ãå ç·ãå é»æ± ã«å°éããã®ãé²ãããã®ã
ã®ã§ãããç²åãå æã®äžã«ãããšãã¯ãå ¥å°å
ã®ïŒéšã¯é»ç¹ãè¿åããããã«æ£ä¹±ãããŠå é»æ±
ã«å°éããããããé»åã®è¡æïŒã€ã³ãã«ã¹ïŒã
瀺ãããã®ã€ã³ãã«ã¹ãéèšããããšã«ãã€ãŠè©Š
æäžã®ç²åã®èšæ°ãè¡ãªãããã éžæçèšæ°æè¡ã䜿ãå Žåã«ã¯ãïŒã€ã®ã©ãã
ã¯ã¹è©Šè¬ã¯èšæ°åšã§èå¥ã§ããããã«ç°ãªããµã€
ãºã®ãã®ã§ãããšéåžžã«å¥œéœåã§ããããã¯ãã³
ãŸãã¯ãµããã¯ãã³ã®ãµã€ãºã®ç²åã䜿ã€ãŠãã®
ãããªç®çã«ã¯ãïŒåã®ãµã€ãºã®å·®ãããã°éåžž
æºè¶³ã§ãããéžæèšæ°ã䜿ãæ¬çºææ¹æ³ã®æäœã
åã«äŸã«ãã€ãŠèª¬æãããšæ¬¡ã®éãã§ããã被éš
Agãå«ãè©Šæã«ãµã€ãºãããããïŒãã¯ãã³ãš
0.1ãã¯ãã³ã®ç¬¬ïŒãšç¬¬ïŒã®ã©ããã¯ã¹è©Šè¬ãå
ãããããã§å ãã第ïŒã®è©Šè¬ã®éã¯ããã€ãŠã
ãããããŠè©Šæäžã®ãã¹ãŠã®Agãšçµåããã®ã«
èŠããéã®éå°ãå ããã第ïŒã®è©Šè¬ã®ïŒéšã¯
AgãšçµåãããããŠããã«ãã€ãŠç¬¬ïŒã®è©Šè¬ã®
ç²åãšçµåããããšã¯é»å®³ãããããããAgãš
çµåããªãã€ã第ïŒã®è©Šè¬ç²åã¯ç¬¬ïŒã®ã©ããã¯
ã¹è©Šè¬ãšçµåããŠåçããããã®ãšãæ··åç©ã¯(i)
è©Šæããã®Agã«çµåãã第ïŒè©Šè¬ã®ç²åïŒäžå
çïŒã(ii)éå°ã®ç¬¬ïŒè©Šè¬ã®ç²åïŒäžåçïŒããã³
(iii)åçããç²åãå«ãã§ãããäžåçã®ç¬¬ïŒãã
ã³ç¬¬ïŒã®è©Šè¬ç²åã®éã«ã¯ãµã€ãºã®å·®ãããã®
ã§ãåçããªã第ïŒè©Šè¬ã®ç²åã®æ°(i)ãèšæ°ãã
ããšãã§ããããããŠãã®ç®å®ïŒãšæšæºçµæãšïŒ
ããè©Šæäžã®Agã®éãèšç®ããããšãã§ããã ãã®ïŒãŸãã¯åæ§ãªïŒæ¹æ³ã§åŠçããããšã¯é
åžžã«å¥œãŸããã æ¬çºæã®æ¹æ³ã¯å°ããAgãšAbãåæããã®ã«
ç¹ã«å¥œéœåã§ãããããã«é¢é£ããŠã¹ããã€ããš
å»è¬ã®åæã¯æãéèŠãªãã®ã«å ¥ãã æ¬çºæãããã«å åã«ç解ãããããã«èª¬æã
ãããã«æ¬¡ã®å®æœäŸã瀺ãã äŸ ïŒ ãã®å®æœäŸã¯ãžãŽãã·ã³ïŒdigoxineïŒã®åæã
説æããäŸã§ããã (a) Abã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ ã©ããã¯ã¹ç²åïŒããŠã±ãã«ã«ç€Ÿè£œåãçŽåŸ
0.09ÎŒã®ããªã¹ãã¬ã³ã§10ééïŒ æžæ¿æ¶²ãšããŠ
å ¥æãããã®ïŒããããã°ãªã·ã³ã§ç·©è¡ããã
é£å¡©æ°ŽïŒdGBSâ20mMã°ãªã·ã³ã34mM
NaClãPHïŒïŒãããã¯Stastnyããã³Horejsiã
Clin.Chim.ActaïŒã782ïŒ1961ïŒã®æ¹æ³ã«ãã€
ãŠäœãããçŸã®æãžãŽãã·ã³è¡æž ã®ãªãããŒã«
å¯æº¶ç»å0.2mg/mlãå«ããäžã«20åã«åžéã
ãããããŠå®€æž©ã§30åéã€ã³ããŠããŒããã
ãã次ã«ïŒmldGBSåœãçã®è¡æž ã¢ã«ããã³
ïŒbSAïŒ10mgã®1/10容éãå ããïŒã©ããã¯ã¹
ãå®å šã«ããçœè³ªã§ã³ãŒãã³ã°ãããããšã確
ãããããïŒããããŠ30åéã€ã³ããŠããŒãã
ãåŸã«ã³ãŒãã³ã°ãããã©ããã¯ã¹ãïŒåé å¿
åé¢ããŠæŽãdGBSäžã«åã³æžæ¿ããããæåŸ
ã«ã³ãŒãã³ã°ãããã©ããã¯ã¹ã¯ïŒmläžïŒmgã®
bSAãå«ãGBSïŒ0.1Mã°ãªã·ã³ã0.17M
NaClãPHïŒïŒäžã«0.5ïŒ æžæ¿æ¶²ãšããŠåã³æžæ¿
ãããã (b) Agã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ ã©ããã¯ã¹ãçŽåŸ1.1ÎŒã®ãã®ã䜿ããã€ã³
ããŠããŒã·ãšã³ãAgâé åç©æ¿åºŠãïŒÎŒïœ/ml
ã«ããŠè¡ãªã€ã以å€ã¯(a)ã«ããããšåãæ¹æ³ã
è¡ãªãããããŠæ¬¡ã«10mg/mlã®ãã©ã³ã¹ããšãª
ã³ã®1/10容éãå ããã Agâé åç©ã¯ãžãŽãã·ã³ãšãšãã¬ã³ã°ãªã³
ãŒã«ãšãé žåçµåãããããšã«ãã€ãŠäœããã
次ã«ãã®è€åäœãéå çµåããããšã«ãã€ãŠã
ãçœè³ªãšããããç¡æ°Žã¢ã«ã³ãŒã«ïŒmläžã«æº¶ã
ãããžãŽãã·ã³50mgã0.1M NaClO42mlãšå ±ã«
25åéã€ã³ããŠããŒããã次ã§ãšãã¬ã³ã°ãªã³
ãŒã«60ÎŒãå ãããã«ïŒåéã€ã³ããŠããŒã
ããããã®åå¿æ··åç©ã次ã«æ°ŽïŒmläžã®äººéã®
ãã©ã³ã¹ããšãªã³60mgã®æº¶æ¶²ã«å ãïŒïŒ
Na2CO3ãå ããŠPHã9.5ãšãããããŠ45åéã€
ã³ããŠããŒããããæ°ããNaBH430mgãæ°ŽïŒ
mlã«æº¶ããã溶液ãå ããæéã€ã³ããŠããŒã·
ãšã³ãç¶ããããã®ææã®æåŸã«ã¯åå¿æ··åç©
ã®PHã¯æªåå¿ã®NaBH4ãå解ããããã«1M
HCOOHã®æ·»å ã«ãã€ãŠ6.5ã«äžãããããã
ããŠããã«ïŒæéã€ã³ããŠããŒãããåŸ1M
NH4OHãå ããŠPHã8.5ã«äžãããããŠè£œåã
ïŒâã§ïŒæ¥ééæãããïŒãã®ä»ã®ãã¹ãŠã®æ
äœã¯å®€æž©ã§è¡ãªã€ããïŒ (c) åæ ãžãŽãã·ã³ã®åæã«äœ¿ãè¡æž ã¯è¡æž 劚害ãæž
ããããã«å ãé žãšå ±ã«å ç±ããããè¡æž 25ÎŒ
ã0.1N HCl25ÎŒãšå ±ã«10åé56âã«å ç±
ãã次ã«2M Na2CO310ÎŒãæ·»å ããŠã¢ã«ã«
ãªæ§ãšããããã®å ç±ãããè¡æž ã«ãAbâã©
ããã¯ã¹ïŒïŒmgbSAïŒmlãå«ãGBSã§ïŒïŒ10ã«
åžéããããã®ïŒ25ÎŒããã³é åã©ããã¯ã¹
ïŒäººéã®ãã©ã³ã¹ããšãªã³ïŒmg/mlãå«ãGBSã§
ïŒïŒïŒã«åžéããããã®ïŒ25ÎŒãå ãããã
ãããæ¯ãšãåŒã€ã³ããŠããŒã¿ãŒäžã§æ°Žå¹³ã«ã
ããŸããããåçŽã«é 眮ããã管ã®äžã§å®€æž©ã§
15åéã€ã³ããŠããŒãããããã®ææã®æåŸ
ã«ã管ã®å 容ç©ãGBS5mlã§åžéãããããŠ
0.01ïŒ ããŠã€ãŒã³20ïŒTween20ïŒãå«ãGBSã§
ããã«20åã«åžéããåŸãã¯ãã³ã³èªåã«ãŠã³
ã¿ãŒã®ãããŠã»ã«ãïŒmlïŒåã®é床ã§éããã
åè©Šæäžã®åçããªãïŒã¢ãããŒïŒã©ããã¯ã¹
ç²åã®çžå¯Ÿçãªæ°ãéžæçå åŠèšæ°ã«ãã€ãŠæ±º
å®ãããïŒåçããç²åã®çžå¯Ÿçãªæ°ãåæ§ã§
ããïŒã第ïŒè¡šã«åŸãããæ°å€ã瀺ãã
ããªã液äœäžã«æåãŸãã¯æäœã®ååšãå®ããã
ãã®ãã®æ¶²äœã®åæã«é¢ãããã®ã§ãããæ¬æ现
æžã«ãããŠã¯ãèšå·AgãAbããã³AbïŒAgã¯ã
ãããæåïŒãã®ããšã°ã«ã¯ä»çäœïŒhapteneïŒ
ããã³æäœãŸãã¯åæ§ãªçµåããçœè³ªã«ãã€ãŠçµ
åããããä»ã®ç©è³ªãå«ãïŒãæäœïŒåæ§ãªçµå
ããçœè³ªãå«ãïŒããã³æäœïŒæåè€åäœãæå³
ãããã®ãšããŠäœ¿ãããã Agã¯é©åœãªAbãšåå¿ããŠAbïŒAgãäœããã®
ã§ãããããŠå€§æµã®å ç«åææ³ããã®åå¿ãå©çš
ããŠããããšã¯ããç¥ãããŠãããããã«ãŸãã
ãªã¹ãã¬ã³ïŒäžè¬çã«ã©ããã¯ã¹ãšåŒã¶ïŒã®ãã
ãªåŸ®ç²åç©è³ªãAbãŸãã¯Agã§ã³ãŒãã³ã°ãã次
ãã§ã³ãŒãã³ã°ãããç²åãè©Šéšããè©Šæ溶液ã«
ãããããããŠãã®ç²åãåçïŒaggultinateïŒ
ããããããŠã©ã®çšåºŠã«åçãããã調ã¹ãããš
ãç¥ãããŠããããã®åçã¯ïŒã€ãŸãã¯ãã以äž
ã®ã³ãŒãã³ã°ãããã©ããã¯ã¹ç²åãšåå¿ããŠå
çãèµ·ãããšã®ã§ããAbãŸãã¯Agãè©Šæäžã«å
åšããããšã瀺ããã®ã§ããã ã³ãŒãã³ã°ãããç²åã®åçã芳枬ããæè¡ã¯
å€ãã®ç¹ã«ãããŠæºè¶³ã§ãããã®ã§ããã®ã«ãå°
ããAgããªãã¡ãã®ååéãçŽ4000ãããå°ãª
ãAgã®åæã«ã¯åé¡ãããããã®ãããªAgã¯äœ¿
çšãã埮ç²åç©è³ªã«å¯Ÿãéåžžã«å°ããããã®ãã
ã«èå¥ã§ãããããªåçããã°ãã°èµ·ããªãããŸ
ãã¯ããçšåºŠãŸã§èµ·ããªãããããã€ãŠãã®æè¡
ã¯å°ããAgã®åæçšã«ã¯å šé¢çã®ä¿¡é Œã¯çœ®ããª
ãã æ¬çºæè ãã¯ä»å液äœäžã®Abããã³Agãåæ
ïŒãã®ååšã®æ€åºããã³ææã«ãããã®éã®æž¬å®
ãå ±ã«è¡ãªãïŒããæ¹è¯ãããæè¡ãéçºããã
ããã¯ç¹ã«å°ããAgïŒãŸãã¯AbïŒã®åæã«æçš
ã§ããããã€ãšå€§ããAgïŒãŸãã¯AbïŒã®åæã«
䜿ãããšãã§ããã æ¬çºæã®ïŒã€ã®å®æ ã¯æ¬¡ã®ãããªåææ³ã®æäŸ
ã§ããã (a)(i) åæãã¹ãç¹å®ã®æåãŸãã¯æäœæåãå«
ã液äœè©Šæã (ii) å®è³ªçã«åäžãªç²å寞æ³ããã€ç¬¬ïŒã®ã©ã
ãã¯ã¹ã«ããæ æããã第ïŒã®è©Šè¬ãããã³ (iii) åèšç¬¬ïŒã©ããã¯ã¹ãšç°ãªãå®è³ªçã«åäž
ãªç²å寞æ³ããã€ç¬¬ïŒã®ã©ããã¯ã¹ã«ããæ
æããã第ïŒã®è©Šè¬ããã ãããã§åèšç¬¬ïŒ
è©Šè¬ã¯åèšç¬¬ïŒè©Šè¬ãšçµåããŠåèšç¬¬ïŒãã
ã³ç¬¬ïŒã©ããã¯ã¹ãåçãããããšãã§ãã
ãããŠå°ãªããšã第ïŒè©Šè¬ã¯åèšç¹å®æåãš
çµåããŠåèšç¬¬ïŒããã³ç¬¬ïŒã©ããã¯ã¹ã®å
çãé»å®³ããããšãã§ãããã®ãšãããã®æ··
åç©ã圢æãã (b) ãã®æ··åç©ãã€ã³ããŠããŒãããŠåèšç¬¬ïŒè©Š
è¬ã競åçã«åèšç¹å®æåããã³åèšç¬¬ïŒè©Šè¬
ãšçµåããããã㊠(c) åèšç¬¬ïŒããã³ç¬¬ïŒã©ããã¯ã¹ã®åçãŸãã¯
äžåçã®çšåºŠããæ··åç©äžã®åçããŠããªãã©
ããã¯ã¹ã®å åŠçæè¡ã«ããéžæçèšæ°ã«ãã
枬å®ããããã«ããè©Šæäžã«ååšããåèšç¹å®
æåãå®éãã ããšããæãã液äœäžã®ç¹å®ã®æåãŸãã¯æäœæ
åãå®éããæ¹æ³ã æ¬çºæã®æ¹æ³ã«åŸã€ãŠãïŒçš®ã®ç°ãªãã©ããã¯
ã¹è©Šè¬ãåæã«äœ¿ããããã®ç¹ãïŒçš®ã®ã©ããã¯
ã¹è©Šè¬ãã䜿ããªãå è¡æè¡ãšç°ãªããšããã§ã
ãããããïŒçš®ã®è©Šè¬ã¯ãã€ããã«æ··åããããš
ãã«åçãããæ··ååã«ã¯åçããªããã®ã§ã
ããäŸãã°äžæ¹ã®ã©ããã¯ã¹è©Šè¬ã¯AgãŸãã¯Ag
âé åç©ã§ãä»æ¹AgãŸãã¯Agâé åç©ãšçµåã
ãAbã§ããããšãã§ããããã®ïŒçš®ã®è©Šè¬ãæ··
åãããšAbã¯AgïŒãŸãã¯Agâé åç©ïŒãšçµåã
ãŠç²åã®åçãèµ·ããããããããªãã埮ç²åè©Š
è¬ã®å°ãªããšãïŒã€ã¯ãããã液äœäžã®è¢«éšç¹æ®
AbãŸãã¯Agãšçµåããããã«éžã°ãããã©ãã
ã¯ã¹è©Šè¬ãéé¢ã®AbãŸãã¯Agãšçµåããããšã¯
ã©ããã¯ã¹è©Šè¬ã®çµåäœçœ®ããµããã®ã§ããã¯ä»
ã®ã©ããã¯ã¹è©Šè¬ãšçµåããããŠåçããããšã¯
ãã¯ãã§ããªããæ··åç©äžã®åçã®çšåºŠã¯ããã
ãŠæ¶²äœäžã®ç¹æ®ãªè¢«éšAgãŸãã¯Abã®éã«äŸåã
ãéã ãæžå°ããïŒããã¯ç¹æ®ãªAgãŸãã¯Abã
ååšããªãå Žåã«æ¶²äœäžã«èµ·ãé以äžã§ããïŒã
ãã®çŸè±¡ã芳å¯ããããšã«ãã€ãŠç¹æ®ãªAbãŸã
ã¯Agã®ååšã確èªããããšãã§ãããããŠåç
ãŸãã¯äžåçã®çšåºŠã枬å®ããããšã«ãã€ãŠç¹æ®
ãªAbãŸãã¯Agã®éãå®éããããšãã§ãããã
ãã¯éåžžæã䟿å®çã«ã¯ãæ¢ç¥æ¿åºŠã®AgãŸãã¯
Abã䜿ã€ãŠåŸãããçµæããæšæºæ²ç·ãäœãã
ãããŠæ¬¡ã«è¢«éšè©Šæäžã®ãããããæªç¥ã®AbãŸ
ãã¯Agã®éãå®éããããã«ãã®æ²ç·ã䜿ãã
ãšã«ãã€ãŠè¡ãªãããã æ¬çºæã®ä¿¡ãããšããã§ã¯ãæ¬çºæã®æ¹æ³ã¯ã
ã©ã®ãããªAgã«ã䜿ãããããŠAgã§ã³ãŒãã³ã°
ãããã©ããã¯ã¹è©Šè¬ã«ãã€ãŠç¹ç°æ§ãå°å ¥ãã
ãããã©ããã¯ã¹è©Šè¬äžã«ã¯ç¹ç°ãªAbãå¿ èŠãš
ããªããããªãã¡äŸãã°ãïŒã€ã®ã©ããã¯ã¹è©Šè¬
äžã®Abã³ãŒãã³ã°ãéç¹ç°æ§ã§ãã®ããã«ãã
ã¯ïŒã€ã®ç°ãªãAgãšåå¿ããããšãã§ãããã
ãŠãããã®Agã®äžã®ãã ïŒã€ã ãïŒããªãã¡
Agâ²ïŒã液äœè©Šæããåæããããšãææããã
ãšãããšããã®å Žåã«ã¯Abãã³ãŒãã³ã°ããè©Š
è¬ãšå ±ã«Agâ²ãã³ãŒãã³ã°ããã©ããã¯ã¹è©Šè¬ã
䜿ãããšã«ãã€ãŠAgâ²ã®åæãè¡ãªãããšãã§ã
ãããã®ææ³ã¯è©Šæäžã®Abã®æ€åºããã³æž¬å®ã«
ãåãããã«ããŠäœ¿ãããšãã§ããã æ¬çºæã®æ¹æ³ã«äœ¿ãããã©ããã¯ã¹è©Šè¬ã¯é¡åŸ®
é¡çãããã¯è¶ é¡åŸ®é¡çãµã€ãºã®ãã®ã§ãããã
ãªãã¡ããã¯äžè¬ã«15ãã¯ãã³ãããå°ããæã
æ®éã«ã¯æ°ãã¯ãã³ãŸãã¯ãµããã¯ãã³ïŒïŒã
100ïœÎŒçšåºŠïŒã®ãµã€ãºã§ããããã®ãããªãµã€
ãºã®ã©ããã¯ã¹ç²åã¯åžè²©ãããŠãããã©ããã¯
ã¹ã®ãããªé¡åŸ®é¡ç埮ç²ç©è³ªã«AbãŸãã¯Agãçµ
åããããšã¯ç¥ãããŠãããããã¯éåžžç²åäžã«
åå¿æ§ã®ã³ãŒãã³ã°ãäžããããŠç²åäžã®AbãŸ
ãã¯AgãååŠçã«çµåããããããã¯åžçãã
ããšã«ãã€ãŠè¡ãªããããããæ æ³ã®å Žåã«ã¯
AbãŸãã¯AgãçŽæ¥ã«ç²åïŒãã®éã«ä»åšããã³
ãŒãã³ã°ããããªãïŒã«çµåããããšãå¯èœã§ã
ããã©ããã¯ã¹è©Šè¬ãäœãæ¹æ³ã¯æ¬çºæã®ç®çã§
ãªãªãããããŠæ¥çã§ããç¥ãããŠãããããã
ãã«ã€ããŠã¯ãã以äžèšèŒããããšã¯ããªãã æ¬çºæã®ç®çã®ããã«ã©ããã¯ã¹ã®ãããªåŸ®ç²
åç©è³ªã«çµåããããšãã§ããAgããã³Abã®äž
ã«ã¯äŸãã°æ¬¡ã®ãããªç©ããããAbãšããŠã¯å
ç«ã°ãããªã³ïŒ§ïŒIgGïŒïŒããã¯äººéã家å ãå±±
çŸããã³çŸã®è¡æž ããã®ãã®ã§ããïŒãªãã³ã«ã
ããã®ïŒŠïŒabïŒâ²ïŒæçã家å IgMãAgãšããŠã¯
人éã®IgMã人éã®èç€ã©ã¯ããŒã²ã³ã人éã®Î±
âèå ããçœè³ªïŒÎ±âfetoproteinïŒã人éã®ã©ã¯
ãããšãªã³ïŒLactoferrinïŒã人éã®è¡æž ãïŒã¢ã«
ããã³ïŒã人éã®ãã©ã³ã¹ããšãªã³
ïŒTransferrinïŒã人éã®ïŒ£âåå¿æ§ããçœè³ªãã
ã³äººéã®IgGã®Fcæçãçã®IgGããã³è¡æž ã¢ã«
ããã³ã銬ã®ããšãªãã³ïŒferritinïŒãéããçœ
質ïŒã人éãããŠã¹ãã©ããããã³ã¢ã«ã¢ããã®
IgGâ²ããã³ç²Ÿè£œããã人éã®IgGã®ïŒãïŒãïŒã
ãã³ïŒäºç¶±ããŸã人éã®è¡æž ã®ã¢ã«ããã³ãIgG
ããã³ãã©ã³ã¹ããšãªã³ãçã®ã¢ã«ããã³ããã³
ãã€ããªããŒã²ã³ããã³éŠ¬ã®ããšãªãã³ã®ããã
ã·ã³é åç©ãçµåãããããšãã§ããããŸã人é
ããã³çã®ã¢ã«ããã³ããã³çã®IgGã®ãžãŽãã·
ã³ïŒDigoxinïŒé åç©ãçµåãããããã®è¡šé¢ã«
åå¿æ§ã«ã«ããã·ã«åºããã€ãŠããããªã¹ãã¬ã³
ã©ããã¯ã¹ç²åã«ãããã·ã³ã¯çŽæ¥ã«çµåããã
ãšãã§ããã åã©ããã¯ã¹è©Šè¬ã®ç²åãµã€ãºã¯å®è³ªçã«äžæ§
ã§ããããšããã³ä»¥äžã«ãã€ãšè©³ããèšèŒããã
ãã«ç¬¬ïŒã®ã©ããã¯ã¹è©Šè¬ã®ç²åãµã€ãºã¯ç¬¬ïŒã®
ã©ããã¯ã¹è©Šè¬ã®ãããšã¯ç°ãªãïŒå°ãªããšãåŸ
è ã®ïŒåã奜ãŸããïŒãã®ã§ããããšã奜ãŸã
ãã ç¹æ®ãªAgãŸãã¯Abã®ååšãæ€åºããæ¹æ³ãå®
æœããã®ã«ã¯ãåçã®é»å®³ãèµ·ã€ããã©ããã確
蚌ããããšã ããå¿ èŠã§ããã被éšè©Šæäžã«Ag
ãŸãã¯Abãæ¯èŒç倧éã«ãããšãã«ã¯ãæ··åç©
ã¯é¡åŸ®é¡ã®ã¹ã©ã€ãã«åºããããŠããã®ã§ãé¡åŸ®
é¡ãéããŠã®èŠ³å¯ã§èçŒã§åçã®é»å®³ãæ€åºãã
ããšãã§ãããïŒã€ã®ç¹ã«å¥œãŸããè©Šéšã¯çä¹³äž
ã®ããã²ã¹ããã³ã®ååšãæ€åºããããã®ãã®ã§
ãããããã§ã¯çä¹³ãšãããã²ã¹ããã³ãŸãã¯ã
ãã²ã¹ããã³é åç©ããæãé¡åŸ®é¡çãããã¯è¶
é¡åŸ®é¡çã©ããã¯ã¹è©Šè¬ãšãããŠããã²ã¹ããã³
ããã³ããã²ã¹ããã³é åç©ã®äž¡æ¹ãšçµåãã
Abããæãé¡åŸ®é¡çãããã¯è¶ é¡åŸ®é¡çã©ãã
ã¯ã¹è©Šè¬ãšã®æ··åç©ãäœããããèçŒã§æ··åç©ã
調ã¹ããšéåžžåçé»å®³ãããããã®ã§ããããã¡
ããåçé»å®³ã®æç¡ã確蚌ããè©Šéšã«ãããŠå®é
åæã«é¢ä¿ããŠåŸè¿°ããæ¹æ³ã®ïŒã€ã䜿ãããšã
ã§ããã æ¬çºæã«ããå®éåæã§ã¯ãã©ããã¯ã¹è©Šè¬ã®
åçãŸãã¯äžåçã®çšåºŠã枬ãããšãå¿ èŠã§ã
ããããã¯çš®ã ã®æ¹æ³ã§è¡ãªãããšãã§ãããäŸ
ãã°åçããç²åãåçããªãç²åããåå¥ãã
ããããåŸè ã®æ°ã枬å®ããããšãã§ããããã®
åå¥ã¯äŸãã°ãéãé å¿åé¢ãŸãã¯ã«ã©ã ã¯ãã
ãã°ã©ãã€ã«ãã€ãŠè¡ãªãããšãã§ããã次ã«äž
åçç²åã®æ°ã枬å®ããã®ã§ããããããã«ã¯äŸ
ãã°èšæ°ã«ããããããã¯ã©ããã¯ã¹è©Šè¬äžã®ç¢º
èªã©ãã«ïŒäŸãã°æŸå°æ§ååïŒã䜿ãããšã«ãã€
ãŠæž¬ãããšãã§ããã ããããªããäžè¬ã«ããã¯é¿ããããšã奜ãŸã
ããããã¯æéãããããããŠèª€å·®ãçãæãã
ãã§ããããã®ä»£ãã«åçãäžåçã®çšåºŠãç®å®
ããããã«åå¿æ··åç©ã枬ãããšã奜ãŸãããã
ãã¯ããèªäœã¯åœæ¥çã§ç¥ãããŠããéžæçèšæ°
æè¡ã䜿ãããšã«ãã€ãŠäŸ¿å©ã«è¡ãªãããšãã§ã
ãããã®æ¹æ³ã§ã¯äŸãã°äžãããããµã€ãºç¯å²ã®
ç²åïŒãã®ç¯å²å€ã®ãµã€ãºã®ç²åã¯ç¡èŠãããïŒ
ã®æ°ãç®å®ããããšãã§ããã ããã¯è¡ãªãïŒã€ã®æ¢ç¥è£ 眮ã¯ãã¯ãã³ã³èªå
èšæ°åšïŒTechnicon AutocouuterïŒã§ããããã®
åºæ¬åã«ãããŠã¯ããã®è£ 眮ã¯åžéãããè©Šæã
å æã«çŽè§ã«ãã³ãã§éããããããŒã»ã«
ïŒFlowcellïŒãå ãééãããããªå åŠç³»ããæ
ããã®ã§ãããå åŠç³»ã®ä»ã®ç«¯ã¯å é»æ± ãããã
ãããŠãããŒã»ã«ã®ããåŸã«ã¯äžå¿ã«é»ç¹ããã€
ãã¬ã³ãºãããããã®é»ç¹ã¯ãããŒã»ã«ãçŽæ¥ã«
éã€ãå ç·ãå é»æ± ã«å°éããã®ãé²ãããã®ã
ã®ã§ãããç²åãå æã®äžã«ãããšãã¯ãå ¥å°å
ã®ïŒéšã¯é»ç¹ãè¿åããããã«æ£ä¹±ãããŠå é»æ±
ã«å°éããããããé»åã®è¡æïŒã€ã³ãã«ã¹ïŒã
瀺ãããã®ã€ã³ãã«ã¹ãéèšããããšã«ãã€ãŠè©Š
æäžã®ç²åã®èšæ°ãè¡ãªãããã éžæçèšæ°æè¡ã䜿ãå Žåã«ã¯ãïŒã€ã®ã©ãã
ã¯ã¹è©Šè¬ã¯èšæ°åšã§èå¥ã§ããããã«ç°ãªããµã€
ãºã®ãã®ã§ãããšéåžžã«å¥œéœåã§ããããã¯ãã³
ãŸãã¯ãµããã¯ãã³ã®ãµã€ãºã®ç²åã䜿ã€ãŠãã®
ãããªç®çã«ã¯ãïŒåã®ãµã€ãºã®å·®ãããã°éåžž
æºè¶³ã§ãããéžæèšæ°ã䜿ãæ¬çºææ¹æ³ã®æäœã
åã«äŸã«ãã€ãŠèª¬æãããšæ¬¡ã®éãã§ããã被éš
Agãå«ãè©Šæã«ãµã€ãºãããããïŒãã¯ãã³ãš
0.1ãã¯ãã³ã®ç¬¬ïŒãšç¬¬ïŒã®ã©ããã¯ã¹è©Šè¬ãå
ãããããã§å ãã第ïŒã®è©Šè¬ã®éã¯ããã€ãŠã
ãããããŠè©Šæäžã®ãã¹ãŠã®Agãšçµåããã®ã«
èŠããéã®éå°ãå ããã第ïŒã®è©Šè¬ã®ïŒéšã¯
AgãšçµåãããããŠããã«ãã€ãŠç¬¬ïŒã®è©Šè¬ã®
ç²åãšçµåããããšã¯é»å®³ãããããããAgãš
çµåããªãã€ã第ïŒã®è©Šè¬ç²åã¯ç¬¬ïŒã®ã©ããã¯
ã¹è©Šè¬ãšçµåããŠåçããããã®ãšãæ··åç©ã¯(i)
è©Šæããã®Agã«çµåãã第ïŒè©Šè¬ã®ç²åïŒäžå
çïŒã(ii)éå°ã®ç¬¬ïŒè©Šè¬ã®ç²åïŒäžåçïŒããã³
(iii)åçããç²åãå«ãã§ãããäžåçã®ç¬¬ïŒãã
ã³ç¬¬ïŒã®è©Šè¬ç²åã®éã«ã¯ãµã€ãºã®å·®ãããã®
ã§ãåçããªã第ïŒè©Šè¬ã®ç²åã®æ°(i)ãèšæ°ãã
ããšãã§ããããããŠãã®ç®å®ïŒãšæšæºçµæãšïŒ
ããè©Šæäžã®Agã®éãèšç®ããããšãã§ããã ãã®ïŒãŸãã¯åæ§ãªïŒæ¹æ³ã§åŠçããããšã¯é
åžžã«å¥œãŸããã æ¬çºæã®æ¹æ³ã¯å°ããAgãšAbãåæããã®ã«
ç¹ã«å¥œéœåã§ãããããã«é¢é£ããŠã¹ããã€ããš
å»è¬ã®åæã¯æãéèŠãªãã®ã«å ¥ãã æ¬çºæãããã«å åã«ç解ãããããã«èª¬æã
ãããã«æ¬¡ã®å®æœäŸã瀺ãã äŸ ïŒ ãã®å®æœäŸã¯ãžãŽãã·ã³ïŒdigoxineïŒã®åæã
説æããäŸã§ããã (a) Abã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ ã©ããã¯ã¹ç²åïŒããŠã±ãã«ã«ç€Ÿè£œåãçŽåŸ
0.09ÎŒã®ããªã¹ãã¬ã³ã§10ééïŒ æžæ¿æ¶²ãšããŠ
å ¥æãããã®ïŒããããã°ãªã·ã³ã§ç·©è¡ããã
é£å¡©æ°ŽïŒdGBSâ20mMã°ãªã·ã³ã34mM
NaClãPHïŒïŒãããã¯Stastnyããã³Horejsiã
Clin.Chim.ActaïŒã782ïŒ1961ïŒã®æ¹æ³ã«ãã€
ãŠäœãããçŸã®æãžãŽãã·ã³è¡æž ã®ãªãããŒã«
å¯æº¶ç»å0.2mg/mlãå«ããäžã«20åã«åžéã
ãããããŠå®€æž©ã§30åéã€ã³ããŠããŒããã
ãã次ã«ïŒmldGBSåœãçã®è¡æž ã¢ã«ããã³
ïŒbSAïŒ10mgã®1/10容éãå ããïŒã©ããã¯ã¹
ãå®å šã«ããçœè³ªã§ã³ãŒãã³ã°ãããããšã確
ãããããïŒããããŠ30åéã€ã³ããŠããŒãã
ãåŸã«ã³ãŒãã³ã°ãããã©ããã¯ã¹ãïŒåé å¿
åé¢ããŠæŽãdGBSäžã«åã³æžæ¿ããããæåŸ
ã«ã³ãŒãã³ã°ãããã©ããã¯ã¹ã¯ïŒmläžïŒmgã®
bSAãå«ãGBSïŒ0.1Mã°ãªã·ã³ã0.17M
NaClãPHïŒïŒäžã«0.5ïŒ æžæ¿æ¶²ãšããŠåã³æžæ¿
ãããã (b) Agã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ ã©ããã¯ã¹ãçŽåŸ1.1ÎŒã®ãã®ã䜿ããã€ã³
ããŠããŒã·ãšã³ãAgâé åç©æ¿åºŠãïŒÎŒïœ/ml
ã«ããŠè¡ãªã€ã以å€ã¯(a)ã«ããããšåãæ¹æ³ã
è¡ãªãããããŠæ¬¡ã«10mg/mlã®ãã©ã³ã¹ããšãª
ã³ã®1/10容éãå ããã Agâé åç©ã¯ãžãŽãã·ã³ãšãšãã¬ã³ã°ãªã³
ãŒã«ãšãé žåçµåãããããšã«ãã€ãŠäœããã
次ã«ãã®è€åäœãéå çµåããããšã«ãã€ãŠã
ãçœè³ªãšããããç¡æ°Žã¢ã«ã³ãŒã«ïŒmläžã«æº¶ã
ãããžãŽãã·ã³50mgã0.1M NaClO42mlãšå ±ã«
25åéã€ã³ããŠããŒããã次ã§ãšãã¬ã³ã°ãªã³
ãŒã«60ÎŒãå ãããã«ïŒåéã€ã³ããŠããŒã
ããããã®åå¿æ··åç©ã次ã«æ°ŽïŒmläžã®äººéã®
ãã©ã³ã¹ããšãªã³60mgã®æº¶æ¶²ã«å ãïŒïŒ
Na2CO3ãå ããŠPHã9.5ãšãããããŠ45åéã€
ã³ããŠããŒããããæ°ããNaBH430mgãæ°ŽïŒ
mlã«æº¶ããã溶液ãå ããæéã€ã³ããŠããŒã·
ãšã³ãç¶ããããã®ææã®æåŸã«ã¯åå¿æ··åç©
ã®PHã¯æªåå¿ã®NaBH4ãå解ããããã«1M
HCOOHã®æ·»å ã«ãã€ãŠ6.5ã«äžãããããã
ããŠããã«ïŒæéã€ã³ããŠããŒãããåŸ1M
NH4OHãå ããŠPHã8.5ã«äžãããããŠè£œåã
ïŒâã§ïŒæ¥ééæãããïŒãã®ä»ã®ãã¹ãŠã®æ
äœã¯å®€æž©ã§è¡ãªã€ããïŒ (c) åæ ãžãŽãã·ã³ã®åæã«äœ¿ãè¡æž ã¯è¡æž 劚害ãæž
ããããã«å ãé žãšå ±ã«å ç±ããããè¡æž 25ÎŒ
ã0.1N HCl25ÎŒãšå ±ã«10åé56âã«å ç±
ãã次ã«2M Na2CO310ÎŒãæ·»å ããŠã¢ã«ã«
ãªæ§ãšããããã®å ç±ãããè¡æž ã«ãAbâã©
ããã¯ã¹ïŒïŒmgbSAïŒmlãå«ãGBSã§ïŒïŒ10ã«
åžéããããã®ïŒ25ÎŒããã³é åã©ããã¯ã¹
ïŒäººéã®ãã©ã³ã¹ããšãªã³ïŒmg/mlãå«ãGBSã§
ïŒïŒïŒã«åžéããããã®ïŒ25ÎŒãå ãããã
ãããæ¯ãšãåŒã€ã³ããŠããŒã¿ãŒäžã§æ°Žå¹³ã«ã
ããŸããããåçŽã«é 眮ããã管ã®äžã§å®€æž©ã§
15åéã€ã³ããŠããŒãããããã®ææã®æåŸ
ã«ã管ã®å 容ç©ãGBS5mlã§åžéãããããŠ
0.01ïŒ ããŠã€ãŒã³20ïŒTween20ïŒãå«ãGBSã§
ããã«20åã«åžéããåŸãã¯ãã³ã³èªåã«ãŠã³
ã¿ãŒã®ãããŠã»ã«ãïŒmlïŒåã®é床ã§éããã
åè©Šæäžã®åçããªãïŒã¢ãããŒïŒã©ããã¯ã¹
ç²åã®çžå¯Ÿçãªæ°ãéžæçå åŠèšæ°ã«ãã€ãŠæ±º
å®ãããïŒåçããç²åã®çžå¯Ÿçãªæ°ãåæ§ã§
ããïŒã第ïŒè¡šã«åŸãããæ°å€ã瀺ãã
ãè¡šã
ãã®æ¹æ³ã¯ä»çäœã®Agâé
åç©ãbSAãšã
ã€ããã«äœ¿ã€ãŠãžãããããšããŒã«ïŒDNPïŒ
ã®å®éã«ãèŠäºã«é©çšãããã ç²åã®éžæçå åŠèšæ°ã«ãããŠãïŒã€ã®ç²å
ã§æ£ä¹±ãããå ã®éã¯ç²åã®ãµã€ãºã«äŸåã
ããããªãã¡ãå é»æ± å ã«çºçããé»åè¡æ
ïŒã€ã³ãã«ã¹ïŒã¯ç²åã®ãµã€ãºã«æ¯äŸãããã
ããŠç°ãªããµã€ãºã®ç²åã¯å¥ã ã«èšæ°ããããš
ãã§ããã第ïŒè¡šã¯ãã¹ãŠã®ç²åãèšæ°ããã®
ãšã¯å察ã«åçããªãç²åïŒã¢ãããŒïŒã ãã
èšæ°ããããšã«ãã€ãŠåŸãããå®éïŒæšæºæ²ç·
ã«å¯ŸããŠãã€ãšæ¡åŒµãããç¯å²ãæäŸããããš
ã«ãã€ãŠïŒã®ç²Ÿç¢ºåºŠã«ãããæ¹è¯ã説æããã
ã®ã§ããããã®è¡šã¯ãŸãåçããªãç²åãšåç
ããç²åãšã®æ¯çïŒã¢ãããŒïŒããªããŒæ¯ïŒã
èšç®ããããšã«ãã€ãŠå®çŸã§ããæ床ã®å€§ããª
å¢å ã説æããŠãããç²åãå šéšèšæ°ããããš
ã«ãã€ãŠæ床ããã³ç²Ÿç¢ºåºŠã®å¢é²ããçµç¹æ±ºå®
ã®ä»ã®æ¹æ³ãšæ¯èŒã«ãã€ãŠå®æããããšãã§ã
ãã第ïŒè¡šã¯ç²åã¯èšæ°ããããšã«ãã€ãŠåŸã
ããçµæã®æ¯èŒã瀺ãã
ã€ããã«äœ¿ã€ãŠãžãããããšããŒã«ïŒDNPïŒ
ã®å®éã«ãèŠäºã«é©çšãããã ç²åã®éžæçå åŠèšæ°ã«ãããŠãïŒã€ã®ç²å
ã§æ£ä¹±ãããå ã®éã¯ç²åã®ãµã€ãºã«äŸåã
ããããªãã¡ãå é»æ± å ã«çºçããé»åè¡æ
ïŒã€ã³ãã«ã¹ïŒã¯ç²åã®ãµã€ãºã«æ¯äŸãããã
ããŠç°ãªããµã€ãºã®ç²åã¯å¥ã ã«èšæ°ããããš
ãã§ããã第ïŒè¡šã¯ãã¹ãŠã®ç²åãèšæ°ããã®
ãšã¯å察ã«åçããªãç²åïŒã¢ãããŒïŒã ãã
èšæ°ããããšã«ãã€ãŠåŸãããå®éïŒæšæºæ²ç·
ã«å¯ŸããŠãã€ãšæ¡åŒµãããç¯å²ãæäŸããããš
ã«ãã€ãŠïŒã®ç²Ÿç¢ºåºŠã«ãããæ¹è¯ã説æããã
ã®ã§ããããã®è¡šã¯ãŸãåçããªãç²åãšåç
ããç²åãšã®æ¯çïŒã¢ãããŒïŒããªããŒæ¯ïŒã
èšç®ããããšã«ãã€ãŠå®çŸã§ããæ床ã®å€§ããª
å¢å ã説æããŠãããç²åãå šéšèšæ°ããããš
ã«ãã€ãŠæ床ããã³ç²Ÿç¢ºåºŠã®å¢é²ããçµç¹æ±ºå®
ã®ä»ã®æ¹æ³ãšæ¯èŒã«ãã€ãŠå®æããããšãã§ã
ãã第ïŒè¡šã¯ç²åã¯èšæ°ããããšã«ãã€ãŠåŸã
ããçµæã®æ¯èŒã瀺ãã
ãè¡šã
ãè¡šã
åæ°å€ã¯hPLãååšããªãå Žåã«åŸãããå€
ã®ïŒ ãšããŠè¡šããããŠããã ãžãŽãã·ã³ã«å¯Ÿããæšæºæ²ç·ãè¡šããïŒçµã®
è©Šæã«å¯ŸããïŒã¢ãããŒã®ã¿ïŒããã³æ¿åºŠåæ
ïŒ400nmã«ãããå åŠå¯åºŠïŒã
ã®ïŒ ãšããŠè¡šããããŠããã ãžãŽãã·ã³ã«å¯Ÿããæšæºæ²ç·ãè¡šããïŒçµã®
è©Šæã«å¯ŸããïŒã¢ãããŒã®ã¿ïŒããã³æ¿åºŠåæ
ïŒ400nmã«ãããå åŠå¯åºŠïŒã
ãè¡šã
åæ°å€ã¯ãžãŽãã·ã³ãïŒnïœ/mlååšããå Ž
åïŒæé«é»æ¢ïŒã«èŠåºãããæ°å€ã®ïŒ ãšããŠè¡š
ããããŠããã äŸ ïŒ ãã®äŸã¯ãããã·ã³ã®åæã説æããã (a) ãããã·ãšçµåããã©ããã¯ã¹ã®è£œæ³ ã©ããã¯ã¹ç²åïŒããŠã±ãã«ã«ç€Ÿè£œåãçŽåŸ
0.857ÎŒã®ã«ã«ããã·ã«åå€æ§ããªã¹ãã¬ã³ïŒ
ã10ééïŒ æžæ¿æ¶²ãšããŠå ¥æãããããããé ž
å¡©ç·©è¡é£å¡©æ°ŽïŒPBSïŒããé žãããªãŠã
50mMãé£å¡©0.17MãPHïŒïŒäžã«20åã«åžé
ããé å¿åé¢ïŒïŒâã12000å転ã§10åéïŒã
ãããŠæ°é®®ãªPBSäžã«åæžæ¿ãæçµçã«ã¯ïŒé
éïŒ ã®æžæ¿æ¶²ãšãããPBS1mläžã®ãããã·ã³
25ÎŒïœãšïŒâãšãã«âïŒâïŒïŒâãžã¡ãã«ã¢ã
ããããã«ïŒâã«ã«ããžã€ããå¡©é žå¡©50ÎŒïœã®
溶液ãïŒâã§äœãããããŠæŽæµããã©ããã¯ã¹
æžæ¿æ¶²250ÎŒãå ããããããïŒâã§ïŒæé
ã€ã³ããŠããŒãããåŸPBSäžã®25ïŒ ãšã¿ããŒã«
ã¢ãã³250ÎŒãå ããŠããã«30åéã€ã³ããŠ
ããŒãããã次ãã§ãã®ã©ããã¯ã¹ãïŒåé å¿
åé¢ããããŠæ°ããPBSïŒæ¯åïŒmlïŒäžã«åæž
æ¿ããããããïŒâã§PBS1ã«å¯ŸããŠ16æé
éæãè¡ãªã€ãããããæçµçã«é å¿åé¢ãã
ããŠã°ãªã·ã³ã§ç·©è¡ãããçã®ã¢ã«ããã³
ïŒbSAïŒïŒïŒ ãå«ãé£å¡©æ°Žäžã«åæžæ¿ããã (b) æ··ååçã«ãããããã·ã³ã®åæ (i) Abã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ ãã®ã©ããã¯ã¹ã®è£œæ³ã¯äŸïŒã«ããããžãŽ
ãã·ã³ã®åæçšã®ãã®ãšå šãåãã§ãããã
ãã®å Žåã®Abã¯å®¶å æãããã·ã³ïŒT4ïŒè¡æž
ããã®ç©ã§ããã (ii) Agã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ äžèš(a)ã®å Žåãšåãã§ããã (iii) åæ T4ãåæãã¹ãè¡æž ã¯ããããªãŠã ãžãš
ãã«ãã«ããã¬ãŒã75mMïŒPH9.2ïŒäžã®ïŒ
âã¢ããªãâããã¿ã¬ã³âïŒâã¹ã«ãã³é ž
1mMã®ç容éãšå ãæ··åããããã®åžéã
ããè¡æž 50ÎŒãbSA1ïŒ ãå«ãGBSäžã®Ab
âã©ããã¯ã¹ã®0.01ïŒ æžæ¿æ¶²25ÎŒããã³äŸ
ïŒã®ãžãŽãã·ã³ã®åæçšãšåãæ¹æ³ã®åãæž
æ¿æ¶²äžã®Agâã©ããã¯ã¹ã®0.1ïŒ æžæ¿æ¶²25ÎŒ
ãšãã€ããã«ã€ã³ããŠããŒãããã第ïŒè¡š
ã¯ãã®ç³»ã䜿ã€ãåŸããã代衚çãªçµæã説
æããã 第 ïŒ è¡š ngT4è¡æž ç²åæ¿åºŠïŒæé«ïŒ ïŒ ïŒ 48 10 51.5 50 59.5 100 89 ãã®å Žåã®æé«å€ã¯Agâã©ããã¯ã¹ã®ã¿
ã«å¯Ÿãããã®ã§ãã€ãããäžã®ãã¹ãŠã®æ°å€
ã¯Agâã©ããã¯ã¹ã®ååšããå Žåã«ãåæ§
ã«èŠãããã äŸ ïŒ ç°ãªãç²å寞æ³ãæ¡çšããå Žåãšå¯Ÿæ¯ããŠåã
ç²å寞æ³ã®ã©ããã¯ã¹ç²åãæ¡çšããå Žåã瀺
ããæé ã¯äŸïŒãšåãã§ããã
åïŒæé«é»æ¢ïŒã«èŠåºãããæ°å€ã®ïŒ ãšããŠè¡š
ããããŠããã äŸ ïŒ ãã®äŸã¯ãããã·ã³ã®åæã説æããã (a) ãããã·ãšçµåããã©ããã¯ã¹ã®è£œæ³ ã©ããã¯ã¹ç²åïŒããŠã±ãã«ã«ç€Ÿè£œåãçŽåŸ
0.857ÎŒã®ã«ã«ããã·ã«åå€æ§ããªã¹ãã¬ã³ïŒ
ã10ééïŒ æžæ¿æ¶²ãšããŠå ¥æãããããããé ž
å¡©ç·©è¡é£å¡©æ°ŽïŒPBSïŒããé žãããªãŠã
50mMãé£å¡©0.17MãPHïŒïŒäžã«20åã«åžé
ããé å¿åé¢ïŒïŒâã12000å転ã§10åéïŒã
ãããŠæ°é®®ãªPBSäžã«åæžæ¿ãæçµçã«ã¯ïŒé
éïŒ ã®æžæ¿æ¶²ãšãããPBS1mläžã®ãããã·ã³
25ÎŒïœãšïŒâãšãã«âïŒâïŒïŒâãžã¡ãã«ã¢ã
ããããã«ïŒâã«ã«ããžã€ããå¡©é žå¡©50ÎŒïœã®
溶液ãïŒâã§äœãããããŠæŽæµããã©ããã¯ã¹
æžæ¿æ¶²250ÎŒãå ããããããïŒâã§ïŒæé
ã€ã³ããŠããŒãããåŸPBSäžã®25ïŒ ãšã¿ããŒã«
ã¢ãã³250ÎŒãå ããŠããã«30åéã€ã³ããŠ
ããŒãããã次ãã§ãã®ã©ããã¯ã¹ãïŒåé å¿
åé¢ããããŠæ°ããPBSïŒæ¯åïŒmlïŒäžã«åæž
æ¿ããããããïŒâã§PBS1ã«å¯ŸããŠ16æé
éæãè¡ãªã€ãããããæçµçã«é å¿åé¢ãã
ããŠã°ãªã·ã³ã§ç·©è¡ãããçã®ã¢ã«ããã³
ïŒbSAïŒïŒïŒ ãå«ãé£å¡©æ°Žäžã«åæžæ¿ããã (b) æ··ååçã«ãããããã·ã³ã®åæ (i) Abã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ ãã®ã©ããã¯ã¹ã®è£œæ³ã¯äŸïŒã«ããããžãŽ
ãã·ã³ã®åæçšã®ãã®ãšå šãåãã§ãããã
ãã®å Žåã®Abã¯å®¶å æãããã·ã³ïŒT4ïŒè¡æž
ããã®ç©ã§ããã (ii) Agã§ã³ãŒãã³ã°ãããã©ããã¯ã¹ã®è£œæ³ äžèš(a)ã®å Žåãšåãã§ããã (iii) åæ T4ãåæãã¹ãè¡æž ã¯ããããªãŠã ãžãš
ãã«ãã«ããã¬ãŒã75mMïŒPH9.2ïŒäžã®ïŒ
âã¢ããªãâããã¿ã¬ã³âïŒâã¹ã«ãã³é ž
1mMã®ç容éãšå ãæ··åããããã®åžéã
ããè¡æž 50ÎŒãbSA1ïŒ ãå«ãGBSäžã®Ab
âã©ããã¯ã¹ã®0.01ïŒ æžæ¿æ¶²25ÎŒããã³äŸ
ïŒã®ãžãŽãã·ã³ã®åæçšãšåãæ¹æ³ã®åãæž
æ¿æ¶²äžã®Agâã©ããã¯ã¹ã®0.1ïŒ æžæ¿æ¶²25ÎŒ
ãšãã€ããã«ã€ã³ããŠããŒãããã第ïŒè¡š
ã¯ãã®ç³»ã䜿ã€ãåŸããã代衚çãªçµæã説
æããã 第 ïŒ è¡š ngT4è¡æž ç²åæ¿åºŠïŒæé«ïŒ ïŒ ïŒ 48 10 51.5 50 59.5 100 89 ãã®å Žåã®æé«å€ã¯Agâã©ããã¯ã¹ã®ã¿
ã«å¯Ÿãããã®ã§ãã€ãããäžã®ãã¹ãŠã®æ°å€
ã¯Agâã©ããã¯ã¹ã®ååšããå Žåã«ãåæ§
ã«èŠãããã äŸ ïŒ ç°ãªãç²å寞æ³ãæ¡çšããå Žåãšå¯Ÿæ¯ããŠåã
ç²å寞æ³ã®ã©ããã¯ã¹ç²åãæ¡çšããå Žåã瀺
ããæé ã¯äŸïŒãšåãã§ããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ (a)(i) åæãã¹ãç¹å®ã®æåãŸãã¯æäœæå
ãå«ã液äœè©Šæã (ii) å®è³ªçã«åäžãªç²å寞æ³ããã€ç¬¬ïŒã®ã©ã
ãã¯ã¹ã«ããæ æããã第ïŒã®è©Šè¬ãããã³ (iii) åèšç¬¬ïŒã©ããã¯ã¹ãšç°ãªãå®è³ªçã«åäž
ãªç²å寞æ³ããã€ç¬¬ïŒã®ã©ããã¯ã¹ã«ããæ
æããã第ïŒã®è©Šè¬ããã ãããã§åèšç¬¬ïŒ
è©Šè¬ã¯åèšç¬¬ïŒè©Šè¬ãšçµåããŠåèšç¬¬ïŒãã
ã³ç¬¬ïŒã©ããã¯ã¹ãåçãããããšãã§ãã
ãããŠå°ãªããšã第ïŒè©Šè¬ã¯åèšç¹å®æåãš
çµåããŠåèšç¬¬ïŒããã³ç¬¬ïŒã©ããã¯ã¹ã®å
çãé»å®³ããããšãã§ãããã®ãšãããã®æ··
åç©ã圢æãã (b) ãã®æ··åç©ãã€ã³ããŠããŒãããŠåèšç¬¬ïŒè©Š
è¬ã競åçã«åèšç¹å®æåããã³åèšç¬¬ïŒè©Šè¬
ãšçµåããããã㊠(c) åèšç¬¬ïŒããã³ç¬¬ïŒã©ããã¯ã¹ã®åçãŸãã¯
äžåçã®çšåºŠããæ··åç©äžã®åçããŠããªãã©
ããã¯ã¹ã®å åŠçæè¡ã«ããéžæçèšæ°ã«ãã
枬å®ããããã«ããè©Šæäžã«ååšããåèšç¹å®
æåãå®éãã ããšããæãã液äœäžã®ç¹å®ã®æåãŸãã¯æäœæ
åãå®éããæ¹æ³ã ïŒ ç¹å®æåãšããŠæååç©è³ªãã第ïŒè©Šè¬ãšã
ãŠåæãã¹ãæååç©è³ªãšçµåã§ããæäœããã
ããŠç¬¬ïŒè©Šè¬ãšããŠåèšæäœãšå®è³ªçã«åãç©è³ª
ã䜿ããåé ïŒã«èšèŒã®æ¹æ³ã ïŒ ç¹å®æåãšããŠæäœãã第ïŒè©Šè¬ãšããŠåèš
æäœãšçµåã§ããæååç©è³ªãããããŠç¬¬ïŒè©Šè¬
ãšããŠåèšæååç©è³ªãšçµåã§ããæäœã䜿ãã
åé ïŒã«èšèŒã®æ¹æ³ã ïŒ åæãã¹ãç¹å®æåãšããŠååéãçŽ4000ã
ããå°ãããã®ã䜿ããåé ïŒã«èšèŒã®æ¹æ³ã ïŒ ç¬¬ïŒã©ããã¯ã¹ãšããŠç¬¬ïŒã©ããã¯ã¹ã®å°ãª
ããšãïŒåã®ç²å寞æ³ããã€ãã®ã䜿ããåé ïŒ
ã«èšèŒã®æ¹æ³ã ïŒ ç¬¬ïŒã©ããã¯ã¹ãšããŠãã®æ¢ç¥éãæ··åå·¥çš
(a)ã«ãããŠäœ¿ããæ··åç©äžã®åçããŠããªã第ïŒ
ã©ããã¯ã¹ãéžæçã«èšæ°ãããåé ïŒã«èšèŒã®
æ¹æ³ã
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5174076A GB1590525A (en) | 1976-12-10 | 1976-12-10 | Biological analysis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS53104726A JPS53104726A (en) | 1978-09-12 |
| JPS6217188B2 true JPS6217188B2 (ja) | 1987-04-16 |
Family
ID=10461194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14777277A Granted JPS53104726A (en) | 1976-12-10 | 1977-12-10 | Test method of liquid containing specific antigen ag or antibody ab |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPS53104726A (ja) |
| CA (1) | CA1089360A (ja) |
| DE (1) | DE2754645C2 (ja) |
| FR (1) | FR2392387A1 (ja) |
| GB (1) | GB1590525A (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH056646Y2 (ja) * | 1987-02-24 | 1993-02-19 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191739A (en) * | 1977-10-17 | 1980-03-04 | General Electric Company | Antigen-antibody reaction assay employing particle aggregation and resistive pulse analysis |
| GB2045431B (en) * | 1979-02-26 | 1983-04-20 | Technicon Instr | Immunoassay utilising two particulate reagents |
| DE2918342A1 (de) * | 1979-05-07 | 1980-11-20 | Behringwerke Ag | Latex-reagenz |
| JPS5821166A (ja) * | 1981-07-30 | 1983-02-07 | Fujitsu Ltd | 被枬å®ç©è³ªåé¢æ¹åŒ |
| DE3212658C3 (de) * | 1982-04-05 | 1993-08-19 | American Hospital Supply Corp | Verfahren zur antigen-bestimmung |
| GB2123146B (en) * | 1982-06-28 | 1985-09-25 | Abbott Lab | Dual parameter flow immunoassays |
| JPH0619349B2 (ja) * | 1983-11-22 | 1994-03-16 | æ±äºå»çšé»åæ ªåŒäŒç€Ÿ | äœæ¶²æååææ¹æ³ããã³ãã®è£ 眮 |
| JPH0619350B2 (ja) * | 1984-05-17 | 1994-03-16 | æ±äºå»çšé»åæ ªåŒäŒç€Ÿ | äœæ¶²æååææ¹æ³ããã³ãã®è£ 眮 |
| JPS61120060A (ja) * | 1984-11-16 | 1986-06-07 | Dai Ichi Pure Chem Co Ltd | å šèªåé£ç¶åæè£ çœ® |
| GB8717862D0 (en) * | 1987-07-28 | 1987-09-03 | Acade Diagnostic Systems Sa Nv | Turbidimetric assay |
| CN111965277A (zh) * | 2020-08-06 | 2020-11-20 | 倩接ç§åŸ·éçç©ç§ææéå ¬åž | äžç§æäœçº¯åæµåºæ¶²èªåšæ¶éè£ çœ® |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639558A (en) * | 1968-02-19 | 1972-02-01 | Louis Csizmas | Immunological reagent particles having proteinaceous materials covalently bonded thereto |
-
1976
- 1976-12-10 GB GB5174076A patent/GB1590525A/en not_active Expired
-
1977
- 1977-12-08 CA CA292,691A patent/CA1089360A/en not_active Expired
- 1977-12-08 DE DE19772754645 patent/DE2754645C2/de not_active Expired
- 1977-12-09 FR FR7737122A patent/FR2392387A1/fr active Granted
- 1977-12-10 JP JP14777277A patent/JPS53104726A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH056646Y2 (ja) * | 1987-02-24 | 1993-02-19 |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2392387A1 (fr) | 1978-12-22 |
| DE2754645A1 (de) | 1978-06-22 |
| DE2754645C2 (de) | 1986-11-20 |
| JPS53104726A (en) | 1978-09-12 |
| GB1590525A (en) | 1981-06-03 |
| FR2392387B1 (ja) | 1982-05-14 |
| CA1089360A (en) | 1980-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4184849A (en) | Mixed agglutination | |
| AU614109B2 (en) | Test method and reagent kit therefor | |
| US4397960A (en) | Immunoassays using F(AB')2 fragments | |
| US4279617A (en) | Iummunoassay involving agglutination | |
| JPS5915860A (ja) | æäœãæåãŸãã¯æäœïŒæåè€åäœã®åææ³ | |
| JPS6314783B2 (ja) | ||
| JPH03504276A (ja) | åææ¹æ³ | |
| JPS60259964A (ja) | åæè©Šæäžã®å ç«åŠçã«æŽ»æ§ãªç©è³ªã®å®éæ³ | |
| US4138213A (en) | Agglutination immunoassay of immune complex with RF or Clq | |
| JPS6217188B2 (ja) | ||
| KR920000057B1 (ko) | í¹ìŽì ìŒë¡ ê²°í©ê°ë¥í 묌ì§ì ìž¡ì ë°©ë² ë° ììœ | |
| CN109459570A (zh) | äžç§å¿«éæ£æµäººäœè¡æ¶²äžé 犻åçè¶äœéå ç«è¯çºžæ¡å¶å€æ¹æ³ | |
| CN113125741A (zh) | ééçŽ åçæ£æµè¯åãè¯åçãç³»ç»åæ£æµæ¹æ³ | |
| JPS6327658B2 (ja) | ||
| CN101446586A (zh) | å ç«åæè¯åååææ¹æ³ | |
| JPH0459587B2 (ja) | ||
| JP3220546B2 (ja) | å ç«è€åäœååšäžã®æåãŸãã¯æäœã®æž¬å®æ¹æ³ | |
| JP4556605B2 (ja) | æšçç©è³ªã®æž¬å®æ¹æ³ããã³æž¬å®è©Šè¬ | |
| EP0260079A1 (en) | Method of assay | |
| JPS63191960A (ja) | ãªã¬ã³ãã®ã¢ãã»ã€æ³ | |
| JP3102827B2 (ja) | ç¹ç°ççµåã¢ãã»ã€è©Šè¬åã³ããã䜿çšãã枬å®æ¹æ³ | |
| JP2003075438A (ja) | ïœïœïœïœâïœïœã®æž¬å®æ¹æ³ | |
| JPH03118472A (ja) | ã€ã³ã¹ãªã³å®éæ¹æ³åã³å®éè©Šè¬ | |
| JPH02259569A (ja) | ãªãŠããå å枬å®æ¹æ³ | |
| JPH0743383B2 (ja) | 蚺æè©Šè¬çšæ äœã©ããã¯ã¹ |